Cargando…

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models

Mutation within the Streptococcus pyogenes (Streptococcus group A; Strep A) covR/S regulatory system has been associated with a hypervirulent phenotype resulting from the upregulation of several virulence factors, including the pore-forming toxin, streptolysin O (SLO). In this study, we utilized a r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langshaw, Emma L., Reynolds, Simone, Ozberk, Victoria, Dooley, Jessica, Calcutt, Ainslie, Zaman, Mehfuz, Walker, Mark J., Batzloff, Michael R., Davies, Mark R., Good, Michael F., Pandey, Manisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972915/ https://www.ncbi.nlm.nih.gov/pubmed/36744883 http://dx.doi.org/10.1128/mbio.03488-22

Ejemplares similares

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
por: Ozberk, Victoria, et al.
Publicado: (2021)

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy
por: Pandey, Manisha, et al.
Publicado: (2018)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma
por: Pandey, Manisha, et al.
Publicado: (2016)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Inactivation of the CovR/S Virulence Regulator Impairs Infection in an Improved Murine Model of Streptococcus pyogenes Naso-Pharyngeal Infection
por: Alam, Faraz M., et al.
Publicado: (2013)

Consequences of the variability of the CovRS and RopB regulators among Streptococcus pyogenes causing human infections
por: Friães, Ana, et al.
Publicado: (2015)

The Streptococcus pyogenes Signaling Peptide SpoV Regulates Streptolysin O and Enhances Survival in Murine Blood
por: Herrera, Andrea L., et al.
Publicado: (2021)

Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection
por: Herrera, Andrea L., et al.
Publicado: (2020)

Correction: Inactivation of the CovR/S Virulence Regulator Impairs Infection in an Improved Murine Model of Streptococcus pyogenes Naso-Pharyngeal Infection
por: Alam, Faraz M., et al.
Publicado: (2013)

Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection
por: Pandey, Manisha, et al.
Publicado: (2009)

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Serotype- and strain- dependent contribution of the sensor kinase CovS of the CovRS two-component system to Streptococcus pyogenes pathogenesis
por: Sugareva, Venelina, et al.
Publicado: (2010)

Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice
por: Pandey, Manisha, et al.
Publicado: (2019)

Streptococcus pyogenes NAD+-Glycohydrolase Reduces Skeletal Muscle βNAD+ Levels Independently of Streptolysin O
por: McIndoo, Eric R., et al.
Publicado: (2022)

Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection
por: Zaman, Mehfuz, et al.
Publicado: (2021)

The CovR regulatory network drives the evolution of Group B Streptococcus virulence
por: Mazzuoli, Maria-Vittoria, et al.
Publicado: (2021)

Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model
por: Reynolds, Simone, et al.
Publicado: (2023)

Activation of the SMU.1882 Transcription by CovR in Streptococcus mutans
por: Chong, Patrick, et al.
Publicado: (2010)

Streptococcus pyogenes Causing Skin and Soft Tissue Infections Are Enriched in the Recently Emerged emm89 Clade 3 and Are Not Associated With Abrogation of CovRS
por: Pato, Catarina, et al.
Publicado: (2018)

CovR-Controlled Global Regulation of Gene Expression in Streptococcus mutans
por: Dmitriev, Alexander, et al.
Publicado: (2011)

Streptolysin O derived from Streptococcus pyogenes inhibits RANKL-induced osteoclastogenesis through the NF-κB signaling pathway
por: Yi, Jin, et al.
Publicado: (2019)

covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus
por: Ashwinkumar Subramenium, Ganapathy, et al.
Publicado: (2015)

Streptolysin O Inhibits Clathrin-Dependent Internalization of Group A Streptococcus
por: Logsdon, Lauren K., et al.
Publicado: (2011)

Streptolysin S induces mitochondrial damage and macrophage death through inhibiting degradation of glycogen synthase kinase-3β in Streptococcus pyogenes infection
por: Tsao, Nina, et al.
Publicado: (2019)

Contribution of cryptic epitopes in designing a group A streptococcal vaccine
por: Ozberk, Victoria, et al.
Publicado: (2018)

Complete Genome Sequence of emm1 Streptococcus pyogenes A20, a Strain with an Intact Two-Component System, CovRS, Isolated from a Patient with Necrotizing Fasciitis
por: Zheng, Po-Xing, et al.
Publicado: (2013)

The Bacterial Markers of Identification of Invasive CovR/CovS-Inactivated Group A Streptococcus
por: Shi, Yong-An, et al.
Publicado: (2022)

Binding of NAD(+)-Glycohydrolase to Streptolysin O Stabilizes Both Toxins and Promotes Virulence of Group A Streptococcus
por: Velarde, Jorge J., et al.
Publicado: (2017)

Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence
por: Chiarot, Emiliano, et al.
Publicado: (2013)

CovS inactivation reduces CovR promoter binding at diverse virulence factor encoding genes in group A Streptococcus
por: Horstmann, Nicola, et al.
Publicado: (2022)

M Protein and Hyaluronic Acid Capsule Are Essential for In Vivo Selection of covRS Mutations Characteristic of Invasive Serotype M1T1 Group A Streptococcus
por: Cole, Jason N., et al.
Publicado: (2010)

Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression
por: Phillips, Zachary N., et al.
Publicado: (2022)

THE PURIFICATION AND PROPERTIES OF STREPTOLYSIN S
por: Cinader, Bernhard, et al.
Publicado: (1950)

PepO is a target of the two-component systems VicRK and CovR required for systemic virulence of Streptococcus mutans
por: Alves, Lívia A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ik4ojpbtpdr57o58e8ml2fikb